Patent ID: 11935637
Assignee: INSULET CORPORATION
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 2:
3. The non-transitory computer readable medium of claim 1, further embodied with programming code as part of the artificial pancreas application executable by the processor, and the processor when executing the programming code is operable to perform further functions to:
retrieve new information related to an amount of insulin delivered by the drug delivery device from an updated insulin delivery history;
determine that an adaptivity mode is active;
in response to the determination that the adaptivity mode is active, set a total daily insulin dosage at a weighted sum of a previously-set total daily insulin dosage and a daily average of insulin doses based on the updated insulin delivery history; and
transmit the set total daily insulin dosage for receipt by a wearable drug delivery device.